3030.TW
Test Research, Inc. [3030.TW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
3030.TW Stock Summary
Top 10 Correlated ETFs
3030.TW
Top 10 Correlated Stocks
3030.TW
In the News
3030.TW Financial details
Company Rating
Buy
Market Cap
23.01B
Income
1B
Revenue
4.44B
Book val./share
30.42
Cash/share
5.72
Dividend
4.5
Dividend %
6.74%
Employees
790
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
15.15
Forward P/E
-
PEG
-3.17
P/S
3.48
P/B
2.28
P/C
16.33
P/FCF
14.59
Quick Ratio
3.07
Current Ratio
4.4
Debt / Equity
0.01
LT Debt / Equity
0
-
-
EPS (TTM)
4.24
EPS next Y
-
EPS next Q
-
EPS this Y
-47.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
1.32%
Revenue last 5Y
0.22%
Revenue Q/Q
27.05%
EPS Q/Q
13.46%
-
-
-
-
SMA20
20.25%
SMA50
39.71%
SMA100
55.74%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
15%
ROC
0.18%
Gross Margin
59%
Oper. Margin
28%
Profit Margin
23%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
58.6-101.5
52W High
-7.52%
52W Low
+61.03%
RSI
64
Rel Volume
3.39
Avg Volume
1.04M
Volume
3.53M
Perf Week
3.89%
Perf Month
20.98%
Perf Quarter
54.13%
Perf Half Y
52.61%
-
-
-
-
Beta
0.275
-
-
Volatility
2.5%, 7.06%
Prev Close
-2.51%
Price
93.4
Change
-4.4%
3030.TW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 18.57 | 20.96 | 23.74 | 28.4 | 18.78 | |
| Net income per share | 3.97 | 4.63 | 5.02 | 8.13 | 4.24 | |
| Operating cash flow per share | 5.75 | 4.74 | 2.5 | 6.21 | 7.95 | |
| Free cash flow per share | 5.52 | 4.52 | 1.85 | 3.33 | 4.24 | |
| Cash per share | 6.37 | 7.59 | 6.02 | 6.07 | 5.72 | |
| Book value per share | 22.79 | 24.14 | 25.81 | 30.76 | 30.42 | |
| Tangible book value per share | 22.7 | 24.03 | 25.69 | 30.66 | 30.42 | |
| Share holders equity per share | 22.79 | 24.14 | 25.81 | 30.76 | 30.42 | |
| Interest debt per share | 0.38 | 0.26 | 0.38 | 0.27 | 0.29 | |
| Market cap | 12.57B | 13.65B | 13.82B | 15.05B | 14.81B | |
| Enterprise value | 11.35B | 12.15B | 12.68B | 13.96B | 14.02B | |
| P/E ratio | 13.39 | 12.5 | 11.66 | 7.83 | 14.79 | |
| Price to sales ratio | 2.86 | 2.76 | 2.46 | 2.24 | 3.34 | |
| POCF ratio | 9.25 | 12.19 | 23.37 | 10.26 | 7.89 | |
| PFCF ratio | 9.63 | 12.79 | 31.67 | 19.11 | 14.8 | |
| P/B Ratio | 2.33 | 2.39 | 2.27 | 2.07 | 2.06 | |
| PTB ratio | 2.33 | 2.39 | 2.27 | 2.07 | 2.06 | |
| EV to sales | 2.59 | 2.45 | 2.26 | 2.08 | 3.16 | |
| Enterprise value over EBITDA | 8.95 | 8.07 | 7.48 | 5.36 | 10.05 | |
| EV to operating cash flow | 8.36 | 10.85 | 21.44 | 9.52 | 7.46 | |
| EV to free cash flow | 8.7 | 11.38 | 29.06 | 17.73 | 14 | |
| Earnings yield | 0.07 | 0.08 | 0.09 | 0.13 | 0.07 | |
| Free cash flow yield | 0.1 | 0.08 | 0.03 | 0.05 | 0.07 | |
| Debt to equity | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net debt to EBITDA | -0.96 | -1 | -0.67 | -0.42 | -0.57 | |
| Current ratio | 4.5 | 4.67 | 3.52 | 3.75 | 3.44 | |
| Interest coverage | 811.03 | 1.01K | 1.01K | 1.05K | 455.64 | |
| Income quality | 1.17 | 0.82 | 0.38 | 0.6 | 1.5 | |
| Dividend Yield | 0.07 | 0.06 | 0.06 | 0.05 | 0.07 | |
| Payout ratio | 0.93 | 0.71 | 0.66 | 0.41 | 1.06 | |
| Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
| Research and developement to revenue | 0.1 | 0.08 | 0.09 | 0.08 | 0.1 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.04 | -0.05 | -0.26 | -0.46 | -0.47 | |
| Capex to revenue | -0.01 | -0.01 | -0.03 | -0.1 | -0.2 | |
| Capex to depreciation | -0.43 | -0.41 | -1.13 | -4.83 | -6.11 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 45.14 | 50.12 | 53.97 | 75.04 | 53.86 | |
| ROIC | 0.17 | 0.19 | 0.19 | 0.26 | 0.14 | |
| Return on tangible assets | 0.14 | 0.16 | 0.15 | 0.21 | 0.11 | |
| Graham Net | 9.2 | 10.24 | 9.25 | 10.84 | 8.54 | |
| Working capital | 3.32B | 3.69B | 4.02B | 4.4B | 3.54B | |
| Tangible asset value | 5.36B | 5.68B | 6.07B | 7.24B | 7.16B | |
| Net current asset value | 3.08B | 3.4B | 3.69B | 4.09B | 3.27B | |
| Invested capital | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Average receivables | 2.07B | 1.96B | 2.17B | 2.73B | 2.7B | |
| Average payables | 418.44M | 475.17M | 705.5M | 699.69M | 495.97M | |
| Average inventory | 825.6M | 836.58M | 1.34B | 1.61B | 1.36B | |
| Days sales outstanding | 164.82 | 143.05 | 156.41 | 166.77 | 192.63 | |
| Days payables outstanding | 87.68 | 80.76 | 130.72 | 61.63 | 102.95 | |
| Days of inventory on hand | 142.06 | 152.62 | 249.19 | 187.02 | 255.19 | |
| Receivables turnover | 2.21 | 2.55 | 2.33 | 2.19 | 1.89 | |
| Payables turnover | 4.16 | 4.52 | 2.79 | 5.92 | 3.55 | |
| Inventory turnover | 2.57 | 2.39 | 1.46 | 1.95 | 1.43 | |
| ROE | 0.17 | 0.19 | 0.19 | 0.26 | 0.14 | |
| Capex per share | -0.23 | -0.22 | -0.66 | -2.88 | -3.71 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 5.97 | 4.94 | 3.96 | 4.35 | 5.52 | |
| Net income per share | 1.35 | 1.15 | 0.87 | 1.04 | 1.18 | |
| Operating cash flow per share | 2.89 | 3.15 | 1.1 | 1.4 | 2.29 | |
| Free cash flow per share | 2.33 | 1.18 | 0.54 | 0.54 | 1.99 | |
| Cash per share | 6.07 | 7.23 | 7.65 | 3.81 | 5.72 | |
| Book value per share | 30.76 | 31.93 | 28.16 | 29.33 | 30.42 | |
| Tangible book value per share | 30.66 | 31.82 | 28.06 | 29.2 | 30.42 | |
| Share holders equity per share | 30.76 | 31.93 | 28.16 | 29.33 | 30.42 | |
| Interest debt per share | 0.27 | 0.23 | 0.2 | 0.29 | 0.29 | |
| Market cap | 15.05B | 15B | 14.27B | 14.53B | 14.81B | |
| Enterprise value | 13.96B | 13.63B | 12.86B | 14.17B | 14.02B | |
| P/E ratio | 11.75 | 13.84 | 17.32 | 14.77 | 13.3 | |
| Price to sales ratio | 10.67 | 12.85 | 15.24 | 14.14 | 11.35 | |
| POCF ratio | 22.01 | 20.13 | 55.01 | 43.83 | 27.33 | |
| PFCF ratio | 27.39 | 53.79 | 112.72 | 114.82 | 31.57 | |
| P/B Ratio | 2.07 | 1.99 | 2.14 | 2.1 | 2.06 | |
| PTB ratio | 2.07 | 1.99 | 2.14 | 2.1 | 2.06 | |
| EV to sales | 9.9 | 11.68 | 13.74 | 13.8 | 10.74 | |
| Enterprise value over EBITDA | 34.02 | 36.55 | 45.45 | 40.06 | 36.37 | |
| EV to operating cash flow | 20.42 | 18.29 | 49.58 | 42.76 | 25.87 | |
| EV to free cash flow | 25.41 | 48.89 | 101.6 | 112.02 | 29.88 | |
| Earnings yield | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | |
| Free cash flow yield | 0.04 | 0.02 | 0.01 | 0.01 | 0.03 | |
| Debt to equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net debt to EBITDA | -2.65 | -3.67 | -4.97 | -1 | -2.06 | |
| Current ratio | 3.75 | 4.17 | 2.57 | 4.4 | 3.44 | |
| Interest coverage | 581.72 | 504.85 | 388.2 | 411.03 | 522.28 | |
| Income quality | 1.71 | 2.2 | 1.02 | 1.06 | 1.55 | |
| Dividend Yield | 0 | 0 | 0 | 0.07 | 0 | |
| Payout ratio | 0 | 0 | 0 | 4.32 | 0 | |
| Sales general and administrative to revenue | 0.03 | 0.04 | 0.03 | 0.05 | 0.04 | |
| Research and developement to revenue | 0.09 | 0.09 | 0.11 | 0.1 | 0.08 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.2 | -0.63 | -0.51 | -0.62 | -0.13 | |
| Capex to revenue | -0.1 | -0.4 | -0.14 | -0.2 | -0.06 | |
| Capex to depreciation | -3.95 | -13.05 | -3.76 | -5.62 | -2.02 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 30.62 | 28.71 | 23.5 | 26.21 | 28.4 | |
| ROIC | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | |
| Return on tangible assets | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | |
| Graham Net | 10.84 | 11.43 | 7.58 | 8.12 | 8.54 | |
| Working capital | 4.4B | 4.39B | 3.39B | 3.47B | 3.54B | |
| Tangible asset value | 7.24B | 7.52B | 6.63B | 6.9B | 7.16B | |
| Net current asset value | 4.09B | 4.1B | 3.1B | 3.17B | 3.27B | |
| Invested capital | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Average receivables | 3.26B | 2.82B | 2.43B | 2.26B | 2.29B | |
| Average payables | 668.06M | 517.06M | 498.73M | 414.99M | 446.31M | |
| Average inventory | 1.58B | 1.46B | 1.44B | 1.37B | 1.29B | |
| Days sales outstanding | 195.68 | 198.47 | 220.56 | 195.74 | 161.42 | |
| Days payables outstanding | 76.35 | 108.48 | 100.33 | 82.88 | 86.39 | |
| Days of inventory on hand | 231.68 | 287.66 | 318.29 | 285.97 | 214.14 | |
| Receivables turnover | 0.46 | 0.45 | 0.41 | 0.46 | 0.56 | |
| Payables turnover | 1.18 | 0.83 | 0.9 | 1.09 | 1.04 | |
| Inventory turnover | 0.39 | 0.31 | 0.28 | 0.31 | 0.42 | |
| ROE | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | |
| Capex per share | -0.57 | -1.97 | -0.56 | -0.87 | -0.31 |
3030.TW Frequently Asked Questions
What is Test Research, Inc. stock symbol ?
Test Research, Inc. is a TW stock and trading under the symbol 3030.TW
What is Test Research, Inc. stock quote today ?
Test Research, Inc. stock price is $93.4 today.
Is Test Research, Inc. stock public?
Yes, Test Research, Inc. is a publicly traded company.
Company Profile
- Volume Average 1.04M
- Market Capitalization 23.01B
- Employee 790
- CEO Mr. Chieh-Yuan Chen
- Headquarters Taipei,TW
- IPO Date 2002-10-30
-
Website
https://www.tri.com.tw 
Test Research, Inc. designs, assembles, manufactures, maintains, repairs, and sells automated inspection and testing equipment in Asia, America, Europe, and internationally. The company offers optical inspection solutions, including 3D solder paste inspection, pre-reflow and post- reflow automated optical inspection, and automated X-ray inspection systems; and manufacturing defects analyzers and in-circuit testers. It also provides smart factory and AI-power solutions, as well as yield management system. In addition, the company offers test and inspection solutions for automotive, semiconductor, and telecommunication industries. Further, it provides after sales services, including trouble shooting, failure analysis, periodic calibration, system maintenance, and parts and accessories warranty. Test Research, Inc. was incorporated in 1989 and is headquartered in Taipei City, Taiwan.
